![](/img/cover-not-exists.png)
Longitudinal QoL in patients with high versus low-intermediate risk prostate cancer treated by RALP: A multicentre study
Devlies, W., De Coster, G., Van Damme, N., Roumeguère, T., Quackels, T., Van Cleynenbreugel, B., Dekuyper, P., Ameye, F., Everaerts, W., Joniau, S.Volume:
18
Journal:
European Urology Supplements
DOI:
10.1016/s1569-9056(19)31149-2
Date:
March, 2019
File:
PDF, 2.20 MB
2019